Abstract:The scientific community has been enthusiastic about DNA microarray technology for pharmacogenomic and toxicogenomic studies In the hope of advancing personalized medicine and drug development. The US Food and Drug Administration has been proactive In promoting the use of pharmacogenomic data In drug development and has Issued a draft guidance for the pharmaceutical Industry on data submissions. However, many challenges and pitfalls are facing the microarray community and regulatory agencies before microarray data can be reliably applied to support regulatory decision making. Four types of factors (i.e., technical, Instrumental, computational and Interpretative) affect the outcome of a microarray study, and a major concern about microarray studies has been the lack of reproducibility and accuracy. Intralaboratory data consistency Is the foundation of reliable knowledge extraction and meaningful crosslaboratory or crossplatform comparisons; unfortunately, It has not been seriously evaluated and demonstrated In every study. Profound problems In data quality have been observed from analyzing published data sets, and many laboratories have been struggling with technical troubleshooting rather than generating reliable data of scientific significance. The microarray community and regulatory agencies must work together to establish a set of consensus quality assurance and quality control criteria for assessing and ensuring data quality, to Identity critical factors affecting data quality, and to optimize and standardize microarray procedures so that biologic Interpretation and decision-making are not based on unreliable data. These fundamental Issues must be adequately addressed before microarray technology can be transformed from a research tool to clinical practices.

Power-law Signatures and Patchiness in Genechip Oligonucleotide Microarrays

Effect of Target and Probe Concentrations on Hybridization in Dna Microarrays

Analyzing High-Density Oligonucleotide Gene Expression Array Data.

Quality Assessment for Short Oligonucleotide Microarray Data

Specific and non specific hybridization of oligonucleotide probes on microarrays

Detecting False Expression Signals in High-Density Oligonucleotide Arrays by an in Silico Approach.

DNA hybridization to mismatched templates: a chip study

Model-based Analysis of Oligonucleotide Arrays: Expression Index Computation and Outlier Detection.

Power enhancement via multivariate outlier testing with gene expression arrays

A study of accuracy and precision in oligonucleotide arrays: extracting more signal at large concentrations

Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application

Large Scale Analysis of Positional Effects of Single-Base Mismatches on Microarray Gene Expression Data

Statistical Applications in Genetics and Molecular Biology

An imputation approach for oligonucleotide microarrays

Quantification of Cross Hybridization on Oligonucleotide Microarrays

Analysis of the Factors Affecting the Accuracy of Detection for Single Base Alterations by Oligonucleotide Microarray

Identification of significant features in DNA microarray data

Quantitative Expression Analysis Using Oligonucleotide Microarrays Based on a Physico-Chemical Model.

Investigation of reproducibility of differentially expressed genes in DNA microarrays through statistical simulation

QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies.

Insight into the Sequence Specificity of a Probe on an Affymetrix GeneChip by Titration Experiments Using Only One Oligonucleotide.